Blueprint Medicines Vs. Recursion Pharmaceuticals Industry Stock Comparison

Buy

59

BPMC
Blueprint Medicines

Last Price:

104.92

Seasonality Move:

13.7%

Buy

74

RXRX
Recursion Pharmaceuticals

Last Price:

9.42

Seasonality Move:

66.82%

Buy

59

Blueprint Medicines (BPMC) is a Buy

Is Blueprint Medicines a Buy, Sell or Hold?

The current Blueprint Medicines [BPMC] share price is $104.96. The Score for BPMC is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

74

Recursion Pharmaceuticals (RXRX) is a Buy

Is Recursion Pharmaceuticals a Buy, Sell or Hold?

The current Recursion Pharmaceuticals [RXRX] share price is $9.42. The Score for RXRX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
RXRX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

The Blueprint Medicines share price today is $104.96
The current trend is moderately bullish and BPMC is experiencing slight selling pressure.

RXRX Stock Price Chart

What is Recursion Pharmaceuticals's stock price today?

The Recursion Pharmaceuticals share price today is $9.42
The current trend is moderately bullish and RXRX is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	4.16	Buy
Relative Strength Index (14 RSI):	59.9	Buy
Chaikin Money Flow:	-50627	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(89.69 - 107.03)	Buy
Bollinger Bands (100):	(81.35 - 98.13)	Buy

RXRX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.19	Buy
Relative Strength Index (14 RSI):	56.02	Buy
Chaikin Money Flow:	1036064	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(7.64 - 9.22)	Buy
Bollinger Bands (100):	(8.49 - 11.93)	Sell

BPMC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	106.98	Sell
20-day SMA:	101.17	Buy
50-day SMA:	94.47	Buy
200-day SMA:	73.73	Buy
8-day EMA:	105.81	Sell
20-day EMA:	102.12	Buy
50-day EMA:	96.03	Buy
200-day EMA:	79.4	Buy

RXRX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	9.29	Buy
20-day SMA:	8.66	Buy
50-day SMA:	9.2	Buy
200-day SMA:	8.98	Buy
8-day EMA:	9.35	Buy
20-day EMA:	8.98	Buy
50-day EMA:	9.23	Buy
200-day EMA:	9.26	Buy

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

Analysts estimate an earnings increase this quarter of $1.17 per share, an increase next quarter of $0.33 per share, an increase this year of $5.90 per share, and an increase next year of $0.62 per share.

Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.15 per share.

Blueprint Medicines Technical Analysis

	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15	May 16	May 17
	May
	06	07	08	09	10	13	14	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Recursion Pharmaceuticals Technical Analysis

	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15	May 16	May 17
	May
	06	07	08	09	10	13	14	15	16	17
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):